Core Products
Avanc Pharma upholds the philosophy of Care for Life and Health and seeks to deliver the best-in-class nervous system, oncology, perioperative drugs and pediatric drugs. It has been granted 37 patents cumulatively. CHANGTUONING ® (Penehyclidine Hydrochloride Injection), a core brand-name drug of the Company, the world’s first-in-class selective anticholinergic drug and a class-I new drug in China, is mainly applied in preanesthetic medication and the treatment of organic phosphorus poisoning and included in the National Reimbursement Drug List, National Essential Drug List, National First-Aid (Emergency Treatment) Drug List and the Catalog of China’s Marketed Drugs; BANGTING® (Hemocoagulase For Injection), another brand-name drug of the Company, is also included in the National Reimbursement Drug List, and as a well recognized brand in the hemostatics field, ranks third by sales among products of the same kind; AODEJIN® (Deproteinised Calf Blood Serum Injection), also a brand-name drug, is China’s first-in-class biological agent intended for the treatment of Nervous Functional Deficiency (NFD), among other diseases, and is a leading brand in the cerebrovascular and peripheral vascular agent segment; XINMAILIN®(L-Glutamine Granules) is mainly used to repair and rebuild damaged gastrointestinal mucosa, replenish glutamine after burns, traumas and major operations, and as an adjunctive therapy for cases of catabolism and hypermetabolism; and LITAINENG® (Octreotide Acetate Injection) is used in urgent remedy of gastroesophageal variceal hemorrhage induced by liver cirrhosis and the treatment of megalakria, and is also included in the National Reimbursement Drug List.
Safety
100% conformity rate in official random inspections
Standards
6 intelligent production lines compliant with cGMP EU-GMP CFDA-GMP standards
Services
pre-sales R&D system, supply chain management system and after-sales service system
Core Products
Avanc Pharma upholds the philosophy of Care for Life and Health and seeks to deliver the best-in-class nervous system, oncology, perioperative drugs and pediatric drugs. It has been granted 37 patents cumulatively. CHANGTUONING ® (Penehyclidine Hydrochloride Injection), a core brand-name drug of the Company, the world’s first-in-class selective anticholinergic drug and a class-I new drug in China, is mainly applied in preanesthetic medication and the treatment of organic phosphorus poisoning and included in the National Reimbursement Drug List, National Essential Drug List, National First-Aid (Emergency Treatment) Drug List and the Catalog of China’s Marketed Drugs; BANGTING® (Hemocoagulase For Injection), another brand-name drug of the Company, is also included in the National Reimbursement Drug List, and as a well recognized brand in the hemostatics field, ranks third by sales among products of the same kind; AODEJIN® (Deproteinised Calf Blood Serum Injection), also a brand-name drug, is China’s first-in-class biological agent intended for the treatment of Nervous Functional Deficiency (NFD), among other diseases, and is a leading brand in the cerebrovascular and peripheral vascular agent segment; XINMAILIN®(L-Glutamine Granules) is mainly used to repair and rebuild damaged gastrointestinal mucosa, replenish glutamine after burns, traumas and major operations, and as an adjunctive therapy for cases of catabolism and hypermetabolism; and LITAINENG® (Octreotide Acetate Injection) is used in urgent remedy of gastroesophageal variceal hemorrhage induced by liver cirrhosis and the treatment of megalakria, and is also included in the National Reimbursement Drug List.
